Global Acute Coronary Syndrome Industry Trends: Where the Market Is Headed by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Acute Coronary Syndrome Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The acute coronary syndrome market size has experienced significant growth in recent years. It is projected to expand from $9.86 billion in 2024 to $10.43 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.8%. The increase observed in the historical period can be ascribed to elements such as public health initiatives, the embrace of telemedicine and remote monitoring, improvements in emergency medical services, and the heightened demand for patient education.

The acute coronary syndrome market size is projected to experience robust expansion over the coming years. It is anticipated to reach $13.43 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 6.5%. The expansion during the forecast period can be attributed to factors such as the demand for personalized medicine, an increase in interventional cardiology procedures, growing awareness, and the global aging population. Prominent trends throughout the forecast period include advancements in diagnostic tools, the integration of health information technology, the implementation of rapid response systems, and overall technological advancements.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12985&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Acute Coronary Syndrome Industry?

The rising occurrence of long-term conditions like coronary artery disease, ischemic heart disease, and vascular diseases is projected to drive the future expansion of the acute coronary syndrome market. Ischemic heart disease, a chronic ailment, arises from the blockage or constriction of the coronary arteries. Addressing acute coronary syndrome (ACS) involves rapidly alleviating symptoms, reducing cardiac harm, and avoiding additional complications for individuals afflicted with diverse acute coronary syndromes, such as ischemic heart disease and vascular diseases. As an illustration, a study from August 2022, featured in the Journal of the American College of Cardiology, a US-based entity, indicated that all four cardiovascular risk factors are expected to increase within the general U.S. population from 2025 to 2060, with dyslipidemia climbing by 27.6% and hypertension by 25.1%. The study’s authors found that heart failure (33.4%) and ischemic heart disease (30.7%) showed the largest projected increases in prevalence, followed by heart attack (16.9%) and stroke (33.8%). Consequently, the widespread occurrence of chronic illnesses like coronary artery disease, ischemic heart disease, and vascular diseases fuels the acute coronary syndrome market.

What Are The Key Segments In The Acute Coronary Syndrome Market?

The acute coronary syndromemarket covered in this report is segmented –

1) By Type: Non-St-Elevation Myocardial Infarction; St-Elevation Myocardial Infarction; Unstable Angina

2) By Treatment: Medications; Statins; Beta blockers; ACE inhibitors; Anticoagulants; Other Treatment

3) By Diagnosis: Stress Test; Blood Tests; Imaging; Other Diagnosis

4) By Route Of Administration: Oral; Parenteral

5) By End-User: Hospitals; Specialty clinics; Other End User

Subsegments:

1) By Non-ST-Elevation Myocardial Infarction: Medical Management; Percutaneous Coronary Intervention (PCI); Coronary Artery Bypass Grafting (CABG)

2) By ST-Elevation Myocardial Infarction: Medical Management; Percutaneous Coronary Intervention (PCI); Coronary Artery Bypass Grafting (CABG)

3) By Unstable Angina: Medical Management; Percutaneous Coronary Intervention (PCI); Coronary Artery Bypass Grafting (CABG)

What Trends Are Expected To Drive The Acute Coronary Syndrome Market?

Leading companies active in the acute coronary syndrome market are devising novel drugs to address acute coronary syndrome and preserve their market standing. Breakthroughs in drug development have the capacity to boost the efficacy of ACS treatment, thereby cutting down the time and resources needed per patient. For example, in June 2023, AGEPHA Pharma USA LLC, a US-based pharmaceutical company, introduced Lodoco, which received approval from the Food and Drug Administration (FDA), a US-based government agency. This marks the inaugural anti-inflammatory atheroprotective cardiovascular treatment that lowers the likelihood of heart stroke, coronary revascularization, myocardial infarction (MI), and cardiovascular death in adult patients with cardiovascular ailments, including acute coronary syndrome.

Who Are The Prominent Global Companies Shaping The Acute Coronary Syndrome Market?

Major companies operating in the acute coronary syndrome market are Pfizer Inc., Johnson and Johnson Limited, Siemens AG, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca PLC, Abbott Laboratories, Medtronic PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Stryker Corporation, GE Healthcare Inc., Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Regeneron Pharmaceuticals Inc., Daiichi Sankyo Company Limited, Terumo Corp., BioMérieux SA, Beckman Coulter Inc., Quidel Corporation, Bio-Rad Laboratories Inc., Biotronik Inc., Randox Laboratories Limited, Nihon Kohden Corporation, Trinity Biotech plc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/acute-coronary-syndrome-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The Acute Coronary Syndrome Market?

North America was the largest region in the acute coronary syndrome market in 2024. The regions covered in acute coronary syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Acute Coronary Syndrome Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12985&type=smp

Browse Through More Reports Similar to the Global Acute Coronary Syndrome Market 2025, By The Business Research Company

Cardiac Assist Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-assist-devices-and-equipment-global-market-report

Cardiac Rhythm Management Crm Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-rhythm-management-crm-devices-and-equipment-global-market-report

Cardiac Pacemakers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-pacemakers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795